INSM Insmed Incorporated

$95.78 -2.71%

Healthcare · Pharmaceutical Preparations

Insmed Incorporated (INSM) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $20.8 billion. Shares last traded at $95.78, 55.0% below their 52-week high. Over the past year the stock is down 3.0%. Net profit margin is -210.5%, below the peer median of -0.1%. Revenue grew 66.7% year over year.

Market Cap

$20.8B

Shares Out

216.8M

EPS (TTM)

$-10.19

P/E Ratio

—

P/S Ratio

34.23

P/B Ratio

29.45

Dividend / Share

—

Dividend Yield

—

52-Week High

$212.81

52-Week Low

$90.42

Volume

392,342

Avg Vol (3m)

213,719.016

Performance

-3.31%

-12.30%

-33.46%

-51.39%

YTD

-45.93%

-2.99%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

38.12

SMA (50)

$122.04

SMA (200)

$153.92

Price vs SMA50

-21.51%

Price vs SMA200

-37.77%

ATR (14)

$5.96

Financials

Revenue

$606M

Net Income

$-1277M

Gross Margin

18.5%

Operating Margin

-205.6%

Net Margin

-210.5%

Return on Equity

-181.1%

Return on Assets

-61.5%

Current Ratio

4.47

Debt / Equity

0.78

Revenue Growth (YoY)

+66.7%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.76	2026-05-07
FY 2025	$-6.42	2026-02-19
Q3 2025	$-4.89	2025-10-30
Q2 2025	$-3.12	2025-08-07
Q1 2026	$-1.42	2026-05-07
FY 2025	$-5.57	2026-02-19

Full earnings history →

Pharmaceutical Preparations peers

INSM vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

34.23 / 3.54 med

+868% premium

Net margin vs peers

-210.5% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.